| [1] |
Fu GF,Lin XH,Han QW,et al.RNA interference remarkably suppresses bcl-2 gene expression in cancer cells in vitro and in vivo.Cancer Biol Ther,2005,4(8):822-829.
|
| [2] |
Shi Y,Zhai H,Wang X,et al.Ribosomal proteins S13 and L23 promote multidrug resistance in gastric cancer cells by suppressing drug-induced apoptosis.Exp Cell Res,2004,296(2):337-346.
|
| [3] |
Sun L,Shi Y,Guo C,et al.Regulation of multidrug resistance by MGr1-antigen in gastric cancer cells.Tumour Biol,2005,27(1):27-35.
|
| [4] |
Bi F,Liu N,Fan D.Small interfering RNA:a new tool for gene therapy.Curr Gene Ther,2003,3(5):411-417.
|
| [5] |
Leung RK,Whittaker PA.RNA interference:From gene silencing to gene-specific therapeutics.Pharmacol Ther,2005,107(2):222-239.
|
| [6] |
Shi Y,Liu Z,Zhang D,et al.RNA interference:A new therapeutic strategy of cancer.Cancer Biol Ther,2005,4(8):830-831.
|
| [7] |
Kirkin V,Joos S,Zomig M.The role of Bcl-2 family members in tumorigenesis.Biochim Biophys Acta,2004,1644(2-3):229-249.
|
| [8] |
McCabe ML,Dlamini Z.The molecular mechanisms of oesophageal cancer.Int Immunopharmacol,2005,5(7-8):1113-1130.
|
| [9] |
O'Neill J,Manion M,Schwartz P,et al.Promises and challenges of targeting Bcl-2 anti-apoptotic proteins for cancer therapy.Biochim Biophys Acta,2004,1705(1):43-51.
|
| [10] |
Waters JS,Webb A,Cunningham D,et al.Phase Ⅰ clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma.J Clin Oncol,2000,18(9):1812-1823.
|